US Patent 9133272 Bispecific binding agents

Patent 9133272 was granted and assigned to Amgen on September, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

91332720

Date of Patent

September 15, 2015

Patent Application Number

134090190

Date Filed

February 29, 2012

Patent Citations Received

‌

US Patent 11939372 Binding agents

Patent Primary Examiner

‌

Sheela J. Huff

Patent abstract

The invention relates to bispecific anti-sclerostin/anti-DKK1 binding agents and combinations of anti-sclerostin and anti-DKK1 binding agents, and related methods of treatment.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9133272 Bispecific binding agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API